Alopecia Areata Trial, Recruiting NCT06841458 Sponsor: Industrial Farmacéutica Cantabria, S.A. Condition: Alopecia Areata
Back to Alopecia Areata

Alopecia Areata Trial, Recruiting

NCT06841458
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You must be willing to sign a written agreement to follow the study rules (compliance consent).
  • You must be willing to sign a written informed consent form for this specific study.
  • You must be male.
  • You must be between 18 and 45 years old.
  • You must have been diagnosed with hair loss with low hair density, rated as mild to moderate (stages II, III, or IV on a standard hair loss scale called the Hamilton-Norwood scale).
  • You must be willing to have a small area of hair (about 1–2 cm², roughly the size of a fingernail) shaved for the duration of the study.
  • Your last participation in any clinical study about hair health must have ended at least 6 months before this study begins.
  • You must have gone at least 30 days without using any specific hair treatments, using only a neutral (plain) shampoo during that time.
  • You must agree not to use any other hair treatments — applied to the skin or taken by mouth — on the target area during the study period; if this becomes necessary, you would need to speak with the lead researcher first.

Who may not be able to join:

  • People who have a gastrointestinal (digestive system) condition, such as diabetes, gastritis, Crohn's disease, celiac disease, stomach ulcers, or food intolerances.
  • People who have other health conditions such as diabetes, high blood pressure, high cholesterol, or gallstones.
  • People who are currently taking, or have taken in the last 3 months, certain medications that affect hair loss — such as Finasteride, Dutasteride, or Minoxidil — or any other medication that could affect the study results (confirm with trial site).
  • People who have ever had any hair restoration procedure, including hair transplants, mesotherapy, or platelet-rich plasma (PRP) therapy.
  • People who follow an unusual or restrictive diet, or who plan to change their eating habits during the study.
  • People who are already taking part in another clinical study with a similar focus during the study period.
  • People who are unable to fully understand the consent form or who may not be able to follow the study rules.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 96 187 45 82

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Industrial Farmacéutica Cantabria, S.A.
Registry
ClinicalTrials.gov
Start date
7 October 2024
Est. completion
1 June 2025

Where this trial is recruiting

🇪🇸 Spain

Primary endpoints

Objective Evaluation of Hair Health Benefits After Six Months of Treatment; Total Terminal Count; Hair Density; Terminal Hair Density; Terminal Hair Proportion; Anagel and Telogen; Hair Mass; Median and Mean Hair Thickness; Hair length

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov